EP 1641479 A2 20060405 - INHIBITION OF STRESS-INDUCED LIGAND-DEPENDENT EGFR ACTIVATION
Title (en)
INHIBITION OF STRESS-INDUCED LIGAND-DEPENDENT EGFR ACTIVATION
Title (de)
HEMMUNG VON STRESSINDUZIERTER LIGANDENABHÄNGIGER EGFR-AKTIVIERUNG
Title (fr)
INHIBITION DE L'ACTIVATION DE L'EGFR, CETTE ACTIVATION ETANT DEPENDANTE D'UN LIGAND ET ETANT INDUITE PAR LE STRESS
Publication
Application
Priority
- EP 2004007329 W 20040705
- EP 03015209 A 20030704
- EP 04740660 A 20040705
Abstract (en)
[origin: EP1493445A1] The present invention relates to the inhibition of stress-induced receptor tyrosine kinase activity by inhibiting a ligand of said receptor tyrosine kinase, particularly an extracellular ligand.
IPC 1-7
IPC 8 full level
A61K 38/18 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); C12N 15/113 (2010.01)
CPC (source: EP US)
A61K 39/3955 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 35/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP); C12N 15/1137 (2013.01 - EP US); C12N 2310/14 (2013.01 - EP US)
Citation (search report)
See references of WO 2005004893A2
Citation (examination)
- WO 0112182 A1 20010222 - MAX PLANCK GESELLSCHAFT [DE], et al
- WO 02089772 A1 20021114 - INEX PHARMACEUTICALS CORP [CA], et al
- WO 03000189 A2 20030103 - BAYLOR COLLEGE MEDICINE [US], et al
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
EP 1493445 A1 20050105; AU 2004255439 A1 20050120; AU 2004255439 B2 20110106; CA 2530967 A1 20050120; EP 1641479 A2 20060405; EP 2275115 A2 20110119; EP 2275115 A3 20110406; JP 2009513515 A 20090402; JP 2011084580 A 20110428; US 2006148694 A1 20060706; WO 2005004893 A2 20050120; WO 2005004893 A3 20050210
DOCDB simple family (application)
EP 03015209 A 20030704; AU 2004255439 A 20040705; CA 2530967 A 20040705; EP 04740660 A 20040705; EP 10182821 A 20040705; EP 2004007329 W 20040705; JP 2006518114 A 20040705; JP 2011015188 A 20110127; US 56321104 A 20040705